Pregnancy and the first months after giving birth are a time of profound physical, hormonal, and psychological changes. Amid sleep deprivation, stress, and adjusting to motherhood, women who have previously experienced depression may face another episode. That is why one of the key goals of modern psychiatry is not only to treat postpartum depression, but also to prevent it from returning during pregnancy.
Researchers in the United States studied whether an online program combining mindfulness practices and cognitive therapy could reduce the risk of depression relapse. In a randomized trial involving 500 women, a new episode was recorded in 33% of participants in the Mindful Mood Balance for Moms program, compared with 44% of women who received standard medical care alone.
The study included women with a history of depression who were in remission. The online program supplemented their usual treatment: around three-quarters of participants in both groups continued taking antidepressants.
The study findings, published on October 20, 2026, in The Lancet Public Health, suggest that digital psychological interventions may help prevent depression during the perinatal period. Participants were followed for up to six months after giving birth.
The study enrolled pregnant women with a history of recurrent depression who had recently taken or were still taking antidepressants. The participants' average age was 32, and they were around 12 weeks pregnant when they joined the study.
The women were randomly assigned to two groups: 249 received access to the program in addition to usual care, while 251 continued with usual care alone. This kind of assignment makes it possible to assess the benefits of an intervention more reliably than simply comparing people who chose to take part with those who declined.
Relapse was assessed using the MINI diagnostic interview. Researchers also measured symptom severity separately using the PHQ-9 questionnaire. This is an important distinction: a temporary dip in mood and a new depressive episode are not the same thing.
That is why the findings relate primarily to preventing another episode in women with a history of depression. The trial did not test meditation as a standalone treatment for current depression.
According to the University of Colorado Boulder’s description, the program includes eight sessions over 12 weeks and periodic check-ins with a coach. Participants work with audio practices, videos, and materials featuring experiences and advice shared by other participants and professionals.
Here, mindfulness means learning to notice thoughts, emotions, and bodily sensations without reacting to them automatically. The cognitive component helps participants recognize habitual thought patterns that may sustain low mood, such as interpreting one setback as proof of personal inadequacy.
For example, after a difficult day, the thought might arise: “I can’t handle anything.” Working with thoughts like these involves noticing when they appear, distinguishing an interpretation from a fact, and choosing what to do next. The goal is not simply to convince yourself to think positively.
This explains the rationale behind the approach, but the trial itself does not establish which specific psychological mechanism produced the result. Researchers tested the program as a whole: mindfulness practices, cognitive skills, and support from a coach.
Another part of the course focuses on recognizing early signs of depression. Participants made a plan in advance for what to do if these signs appeared. This preparation connects self-help skills with reaching out for support.
According to the study abstract on PubMed, a new episode was recorded in 81 of the 249 participants in the program group and 111 of the 251 women in the control group. The difference between the rounded percentages was 11 percentage points. In other words, for every 100 participants in the program group, there were about 11 fewer relapses over the study period.
This is a clinically meaningful result: it means fewer repeat episodes of depression. At the same time, researchers found a benefit in depressive symptom severity during the 12-week course, but not across the entire follow-up period. Preventing relapse and achieving a lasting reduction in overall symptom burden were different outcomes.
The primary result was statistically significant, but the range of uncertainty allowed for anything from a substantial benefit to an advantage close to zero. In addition, 389 of the 500 participants, or 78%, provided assessment data at six months postpartum. Incomplete follow-up limits confidence in the precise size of the effect.
For a woman with a history of recurrent depression, the study offers a reason to discuss additional preventive support with her healthcare provider during pregnancy. The online format makes it possible to take part without regular travel, although the program still requires time and commitment.
The intervention tested is quite different from listening to meditation recordings on your own: it has a structured course, a cognitive component, check-ins with a coach, and a plan for responding to early signs of worsening symptoms. The findings therefore cannot automatically be applied to any mindfulness app.
The trial also did not compare the program with antidepressants or assess the safety of stopping them. You should not change prescribed treatment based on this news. If symptoms return, contact your healthcare provider rather than waiting until the course ends.
It is not yet known whether the benefits continue beyond six months postpartum. This is an important question for long-term prevention: the study points to a useful additional tool, but does not establish how long support may be needed after the program ends.
It is not known. The trial studied a specific, multi-component program that included cognitive skills and check-ins with a coach. There is no evidence that regular apps produce equivalent results.
This trial does not provide a direct answer. Participants enrolled during pregnancy, so the effectiveness of starting the same program only after giving birth would need to be assessed separately.
No, that conclusion cannot be drawn from the findings presented. A lower relapse rate among mothers does not, by itself, establish an effect on children’s health or development.
How was this article?
Share
